MicroRNA-139-3p indicates a poor prognosis of colon cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 11, 2014, Pages 8046-8052

  Liu, Xiaojing ^a   Duan, Bensong ^b   Dong, Yuanyuan ^c   He, Chengzhi ^b   Zhou, Hongmei ^d,e   Sheng, Haihui ^d,e   Gao, Hengjun ^b,e   Zhang, Xizhi ^a  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

^d Institute of CMC Biobank and Translational Medicine   (China)

^e NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

Author keywords

Colon cancer; MicroRNA; miR 139; miR 139 3p; Prognosis

Indexed keywords

MICRORNA; MIRN139 MICRORNA, HUMAN;

AGE; AGED; CANCER STAGING; COLON TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE;

EID: 84919684192     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Siegel R, Ma J, Zou Z and Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Wan DS. [Epidemiologic trend of and strategies for colorectal cancer]. Ai Zheng 2009; 28: 897-902.
3. Li HL, Gao YT, Zheng Y, Zhang W, Gao LF, Xu B and Xiang YB. [Incidence trends of colorectal cancer in urban Shanghai, 1973-2005]. Zhonghua Yu Fang Yi Xue Za Zhi 2009; 43: 875-879.
4. Chen C, Hong H, Chen L, Shi X, Chen Y and Weng Q. Association of microRNA polymorphisms with the risk of myocardial infarction in a Chinese population. Tohoku J Exp Med 2014; 233: 89-94.
5. Yu H, Gao G, Jiang L, Guo L, Lin M, Jiao X, Jia W and Huang J. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 2013; 6: 2904-2911.
6. Wu C, Cao Y, He Z, He J, Hu C, Duan H and Jiang J. Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer. Tohoku J Exp Med 2014; 232: 85-95.
7. Oom AL, Humphries BA and Yang C. MicroRNAs: Novel Players in Cancer Diagnosis and Therapies. Biomed Res Int 2014; 2014: 959461.
8. Wu W, Sun M, Zou GM and Chen J. MicroRNA and cancer: Current status and prospective. Int J Cancer 2007; 120: 953-960.
9. Long LM, Huang GQ, Zhu HY, Guo YH, Liu YS and Huo JR. Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2. J Transl Med 2013; 11: 275.
10. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, Wakabayashi G, Mori M and Mimori K. Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carci-nogenesis 2012; 33: 2391-2397.
11. Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q and Liu J. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 2012; 84: 320-330.
12. Krishnan K, Steptoe AL, Martin HC, Patta-biraman DR, Nones K, Waddell N, Maria-segaram M, Simpson PT, Lakhani SR, Vlassov A, Grimmond SM and Cloonan N. miR-139-5p is a regulator of metastatic pathways in breast cancer. RNA 2013; 19: 1767-1780.
13. Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo ZY, Zhao J, Meng YL, Ren XL, Wang T, Li Q, Jin BQ, Yao LB, Wang RA, Fan DM, Chen SY, Jia LT and Yang AG. HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells. Gastroenterology 2011; 141: 2076-U2210.
14. Fan Q, He M, Deng X, Wu WK, Zhao L, Tang J, Wen G, Sun X and Liu Y. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. Cell Biochem Funct 2013; 31: 319-324.
15. Guo HY, Hu XB, Ge SF, Qian GX and Zhang JJ. Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. Int J Biochem Cell Biol 2012; 44: 1465-1472.
16. Rask L, Balslev E, Sokilde R, Hogdall E, Flyger H, Eriksen J and Litman T. Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Cell Oncol (Dordr) 2014; 37: 215-227.
17. Luo HN, Wang ZH, Sheng Y, Zhang Q, Yan J, Hou J, Zhu K, Cheng Y, Xu YL, Zhang XH, Xu M and Ren XY. MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol 2014; 31: 789.
18. Gu W, Li X and Wang J. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Oncol Rep 2014; 31: 397-404.
19. Obrocea FL, Sajin M, Marinescu EC and Stoica D. Colorectal cancer and the 7th revision of the TNM staging system: review of changes and suggestions for uniform pathologic reporting. Rom J Morphol Embryol 2011; 52: 537-544.
20. Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H and Yu H. Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am J Transl Res 2014; 6: 391-401.
21. Yu H, Duan B, Jiang L, Lin M, Sheng H, Huang J and Gao H. Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy. Am J Transl Res 2013; 6: 71-77.
22. Walter V, Jansen L, Hoffmeister M and Brenner H. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol 2014; 25: 1517-1525.
23. Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ and Yu J. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene 2013; 32: 5078-5088.
24. Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu CW, Wang K, Zheng S, Ng SS, Chan FK, Sung JJ and Yu J. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer 2014; 13: 124.
25. Hayes J, Peruzzi PP and Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 2014; 20: 460-469.
26. Vicinus B, Rubie C, Stegmaier N, Frick VO, Kolsch K, Kauffels A, Ghadjar P, Wagner M and Glanemann M. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: Significance of their regulation. Oncol Rep 2013; 30: 1285-1292.
27. Vega AB, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots A, Serra-Aracil X, Oliva JC, Ruiz A and Saigi E. microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers. Oncol Rep 2013; 30: 320-326.
28. Zhang LJ, Dong YJ, Zhu NN, Tsoi H, Zhao ZR, Wu CW, Wang KN, Zheng S, Ng SSM, Chan FKL, Sung JJY and Yu J. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer 2014; 13: 124.
29. Chang KH, Miller N, Kheirelseid EAH, Lemetre C, Ball GR, Smith MJ, Regan M, McAnena OJ and Kerin MJ. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease. Int J Colorectal Dis 2011; 26: 1415-1422.
30. Noren Hooten N, Fitzpatrick M, Wood WH 3rd, De S, Ejiogu N, Zhang Y, Mattison JA, Becker KG, Zonderman AB and Evans MK. Age-related changes in microRNA levels in serum. Aging (Albany NY) 2013; 5: 725-740.
31. Zhang JB, Zhu XN, Cui J, Chen P, Wang SM and Wang JS. [Differential expressions of microRNA between young and senescent endothelial cells]. Zhonghua Yi Xue Za Zhi 2012; 92: 2205-2209.
32. Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, Kirkwood JM and Panelli MC. Microrna profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med 2010; 8: 27.
33. Pena-Chilet M, Martinez MT, Perez-Fidalgo JA, Peiro-Chova L, Oltra SS, Tormo E, Alonso-Yuste E, Martinez-Delgado B, Eroles P, Climent J, Burgues O, Ferrer-Lozano J, Bosch A, Lluch A and Ribas G. MicroRNA profile in very young women with breast cancer. Bmc Cancer 2014; 14: 529.
34. Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C, Zhou L, Hu Y, Wang Q, Ni S, Fei B, Wang W, Du X, Hua D and Huang Z. MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein Cell Protein Cell 2014; 5: 851-61.